Cargando…

ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA

BACKGROUND: Non-Hodgkin’s lymphomas (NHL) are primary neoplasms derived from lymphocytes, and Kaposi’s sarcoma (SK) is a multicentric disease of viral etiology and is associated with HIV. AIM: To study the etiopathogenesis and clinical characteristics of NHL and KS, describing their mutual factors....

Descripción completa

Detalles Bibliográficos
Autores principales: PETROIANU, Andy, ALBERTI, Luiz Ronaldo, ORSI, Vanessa Lacerda, VIANA, Flávia Costa Teixeira, MOURA, Carolina Braga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Colégio Brasileiro de Cirurgia Digestiva 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682145/
https://www.ncbi.nlm.nih.gov/pubmed/33237165
http://dx.doi.org/10.1590/0102-672020200002e1521
_version_ 1783612651041980416
author PETROIANU, Andy
ALBERTI, Luiz Ronaldo
ORSI, Vanessa Lacerda
VIANA, Flávia Costa Teixeira
MOURA, Carolina Braga
author_facet PETROIANU, Andy
ALBERTI, Luiz Ronaldo
ORSI, Vanessa Lacerda
VIANA, Flávia Costa Teixeira
MOURA, Carolina Braga
author_sort PETROIANU, Andy
collection PubMed
description BACKGROUND: Non-Hodgkin’s lymphomas (NHL) are primary neoplasms derived from lymphocytes, and Kaposi’s sarcoma (SK) is a multicentric disease of viral etiology and is associated with HIV. AIM: To study the etiopathogenesis and clinical characteristics of NHL and KS, describing their mutual factors. METHODS: This retrospective investigation was performed on 101 medical charts. The patients were studied according to their age, gender, and HIV-positivity, following the PRISMA guidelines. The characteristics of the tumors and comorbidities were analyzed according to their age and lymphatic metastasis. RESULTS: The mean age of the patients ranged between 15-87 years for NHL and between 25-54 for KS, but the age of patients with NHL associated with HIV did not surpass 34 years. The ratio male: female was 1,8:1 for NHL, but only men presented KS. HIV-positivity was found in five patients with NHL and in 14 with KS. The stages of NHL were: I (21%), II (18,4%), III (26,3%), and IV (34,2%), but KS were found only at III (40%) and IV (60%) stages. The lymphatic metastases were positive in 62 patients NHL and in four with KS. HIV-positivity occurred in 60% of patients with NHL and in 50% with KS. CONCLUSION: The HIV seropositivity was revealed for most of patients during the NHL and SK propaedeutic and none of them present clinical manifestations of AIDS. NHL associated with HIV was found only in young patients. NHL and KS patients have similar epidemiological, clinical, and therapeutic characteristics.
format Online
Article
Text
id pubmed-7682145
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Colégio Brasileiro de Cirurgia Digestiva
record_format MEDLINE/PubMed
spelling pubmed-76821452020-11-25 ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA PETROIANU, Andy ALBERTI, Luiz Ronaldo ORSI, Vanessa Lacerda VIANA, Flávia Costa Teixeira MOURA, Carolina Braga Arq Bras Cir Dig Original Article BACKGROUND: Non-Hodgkin’s lymphomas (NHL) are primary neoplasms derived from lymphocytes, and Kaposi’s sarcoma (SK) is a multicentric disease of viral etiology and is associated with HIV. AIM: To study the etiopathogenesis and clinical characteristics of NHL and KS, describing their mutual factors. METHODS: This retrospective investigation was performed on 101 medical charts. The patients were studied according to their age, gender, and HIV-positivity, following the PRISMA guidelines. The characteristics of the tumors and comorbidities were analyzed according to their age and lymphatic metastasis. RESULTS: The mean age of the patients ranged between 15-87 years for NHL and between 25-54 for KS, but the age of patients with NHL associated with HIV did not surpass 34 years. The ratio male: female was 1,8:1 for NHL, but only men presented KS. HIV-positivity was found in five patients with NHL and in 14 with KS. The stages of NHL were: I (21%), II (18,4%), III (26,3%), and IV (34,2%), but KS were found only at III (40%) and IV (60%) stages. The lymphatic metastases were positive in 62 patients NHL and in four with KS. HIV-positivity occurred in 60% of patients with NHL and in 50% with KS. CONCLUSION: The HIV seropositivity was revealed for most of patients during the NHL and SK propaedeutic and none of them present clinical manifestations of AIDS. NHL associated with HIV was found only in young patients. NHL and KS patients have similar epidemiological, clinical, and therapeutic characteristics. Colégio Brasileiro de Cirurgia Digestiva 2020-11-20 /pmc/articles/PMC7682145/ /pubmed/33237165 http://dx.doi.org/10.1590/0102-672020200002e1521 Text en https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Original Article
PETROIANU, Andy
ALBERTI, Luiz Ronaldo
ORSI, Vanessa Lacerda
VIANA, Flávia Costa Teixeira
MOURA, Carolina Braga
ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA
title ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA
title_full ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA
title_fullStr ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA
title_full_unstemmed ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA
title_short ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN’S LYMPHOMA AND KAPOSI’S SARCOMA
title_sort etiopathogenic, epidemiologic and clinical-therapeutic comparison of non-hodgkin’s lymphoma and kaposi’s sarcoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682145/
https://www.ncbi.nlm.nih.gov/pubmed/33237165
http://dx.doi.org/10.1590/0102-672020200002e1521
work_keys_str_mv AT petroianuandy etiopathogenicepidemiologicandclinicaltherapeuticcomparisonofnonhodgkinslymphomaandkaposissarcoma
AT albertiluizronaldo etiopathogenicepidemiologicandclinicaltherapeuticcomparisonofnonhodgkinslymphomaandkaposissarcoma
AT orsivanessalacerda etiopathogenicepidemiologicandclinicaltherapeuticcomparisonofnonhodgkinslymphomaandkaposissarcoma
AT vianaflaviacostateixeira etiopathogenicepidemiologicandclinicaltherapeuticcomparisonofnonhodgkinslymphomaandkaposissarcoma
AT mouracarolinabraga etiopathogenicepidemiologicandclinicaltherapeuticcomparisonofnonhodgkinslymphomaandkaposissarcoma